{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:27:21Z","timestamp":1787304441802,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["R01DK129388"],"award-info":[{"award-number":["R01DK129388"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["U54GM115677"],"award-info":[{"award-number":["U54GM115677"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Negotiated contracts with Medicare Advantage resulted in differing reimbursement rates and profit margins depending on the size of the dialysis organization.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Small dialysis organizations reported absorbing bad debt and expressed concern about financial sustainability and market consolidation.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Dialysis organizations described kidney-related medical care costs as substantial even with Medicare Advantage cost-sharing strategies.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Following the 2021 policy change that opened Medicare Advantage (MA) enrollment to all Medicare beneficiaries with kidney failure, MA enrollment among this population has risen sharply. However, little is known about the financial and organizational consequences of this expansion for dialysis providers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Administrative leadership and clinical staff from two large national and four small regional dialysis organizations were recruited to participate in semistructured, in-depth interviews. Interviews were conducted with executive, financial, and clinical staff from January 2022 to May 2024. This descriptive qualitative study analyzed interview transcripts using a modified grounded theory and content analysis approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Interviews were conducted with 37 administrative leadership and clinical staff from six dialysis organizations. Three main themes were identified reflecting their experiences managing the fiscal repercussions of MA expansion: (\n                      <jats:italic toggle=\"yes\">1<\/jats:italic>\n                      ) contract negotiations with MA plans were described as complicated, with large dialysis organizations securing more favorable rates and profit margins than small dialysis organizations; (\n                      <jats:italic toggle=\"yes\">2<\/jats:italic>\n                      ) although MA out-of-pocket caps were cost-saving for patients with kidney failure, the expenses before reaching maximums were described by dialysis leadership and staff as a significant financial burden for their patients, often leading to medical debt\u2014a cost that small dialysis organizations reported absorbing as bad debt; and (\n                      <jats:italic toggle=\"yes\">3<\/jats:italic>\n                      ) dialysis organizations expressed concerns around the long-term financial impacts of MA expansion noting high health care costs, MA enrollment trends by their patients with kidney failure, and financial instability amid market consolidation for small dialysis providers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MA expansion created uneven financial consequences for large and small dialysis organizations, raising concerns about consolidation, sustainability, and care quality. Ongoing monitoring is needed to ensure that the rapid growth of MA does not compromise the financial stability of dialysis providers or access and quality of care for patients with kidney failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000001161","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:01:12Z","timestamp":1784736072000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dialysis Organization Perspectives on the Financial Repercussions of the Expansion of Medicare Advantage"],"prefix":"10.2215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-7626","authenticated-orcid":false,"given":"Joan F.","family":"Brazier","sequence":"first","affiliation":[{"name":"Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8555-9011","authenticated-orcid":false,"given":"Denise A.","family":"Tyler","sequence":"additional","affiliation":[{"name":"Scripps Gerontology Center, Miami University, Oxford, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0811-6900","authenticated-orcid":false,"given":"Ankur D.","family":"Shah","sequence":"additional","affiliation":[{"name":"Warren Alpert Medical School of Brown University, Providence, Rhode Island"},{"name":"Division of Kidney Disease and Hypertension, Rhode Island Hospital, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal N.","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1643-2732","authenticated-orcid":false,"given":"Emily A.","family":"Gadbois","sequence":"additional","affiliation":[{"name":"Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"1","key":"B2-20260821","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/13696998.2024.2342210","article-title":"Exploring kidney dialysis costs in the United States: a scoping review","volume":"27","author":"Stewart","year":"2024","journal-title":"J Med Econ."},{"issue":"9","key":"B10-20260821","doi-asserted-by":"crossref","first-page":"e2432772","DOI":"10.1001\/jamanetworkopen.2024.32772","article-title":"Medicare advantage enrollment following the 21st century cures act in adults with end-stage renal disease","volume":"7","author":"Nguyen","year":"2024","journal-title":"JAMA Netw Open."},{"issue":"10","key":"B11-20260821","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jama.2023.1426","article-title":"Medicare advantage enrollment among beneficiaries with end-stage renal disease in the first year of the 21st century cures act","volume":"329","author":"Nguyen","year":"2023","journal-title":"JAMA."},{"issue":"4","key":"B14-20260821","doi-asserted-by":"crossref","first-page":"e14308","DOI":"10.1111\/1475-6773.14308","article-title":"Restrictiveness of medicare advantage provider networks across physician specialties","volume":"59","author":"Feyman","year":"2024","journal-title":"Health Serv Res."},{"issue":"4","key":"B15-20260821","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamainternmed.2018.7639","article-title":"Analysis of drivers of disenrollment and plan switching among medicare advantage beneficiaries","volume":"179","author":"Meyers","year":"2019","journal-title":"JAMA Intern Med."},{"issue":"2","key":"B16-20260821","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s11606-020-06534-2","article-title":"Narrow primary care networks in medicare advantage","volume":"37","author":"Meyers","year":"2022","journal-title":"J Gen Intern Med."},{"issue":"6","key":"B17-20260821","doi-asserted-by":"crossref","first-page":"e2516359","DOI":"10.1001\/jamanetworkopen.2025.16359","article-title":"Expansion and marketing of medicare advantage to persons with end-stage kidney disease","volume":"8","author":"Brazier","year":"2025","journal-title":"JAMA Netw Open."},{"issue":"6","key":"B18-20260821","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1681\/ASN.0000000667","article-title":"Implications of increased medicare advantage enrollment for access to kidney transplant waitlisting","volume":"36","author":"Adler","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"B20-20260821","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1377\/hlthaff.2021.02009","article-title":"Medicare advantage plans pay large markups to consolidated dialysis organizations","volume":"41","author":"Lin","year":"2022","journal-title":"Health Aff (Millwood)."},{"issue":"3","key":"B21-20260821","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1377\/hlthaff.2024.01142","article-title":"Dialysis facility participation in medicare advantage networks was highest for large dialysis organizations in 2021","volume":"44","author":"Oh","year":"2025","journal-title":"Health Aff (Millwood)."},{"issue":"2","key":"B22-20260821","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1377\/hlthaff.2022.01044","article-title":"Narrow dialysis networks in medicare advantage: exposure by race, ethnicity, and dual eligibility","volume":"42","author":"Oh","year":"2023","journal-title":"Health Aff (Millwood)."},{"issue":"5","key":"B23-20260821","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/10775587251349298","article-title":"Medicare advantage plan and chronic kidney disease care management company partnerships after the 21st century cures act","volume":"82","author":"Tyler","year":"2025","journal-title":"Med Care Res Rev."},{"issue":"4","key":"B24-20260821","doi-asserted-by":"crossref","first-page":"180","DOI":"10.37765\/ajmc.2022.88861","article-title":"Comparison of mortality between medicare advantage and traditional medicare beneficiaries with kidney failure","volume":"28","author":"Kim","year":"2022","journal-title":"Am J Manag Care."},{"issue":"4","key":"B27-20260821","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-0009.2005.00397.x","article-title":"Evaluating the quality of medical care. 1966","volume":"83","author":"Donabedian","year":"2005","journal-title":"Milbank Q."},{"issue":"4","key":"B30-20260821","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","article-title":"Saturation in qualitative research: exploring its conceptualization and operationalization","volume":"52","author":"Saunders","year":"2018","journal-title":"Qual Quant."},{"issue":"11","key":"B31-20260821","doi-asserted-by":"crossref","first-page":"e213626","DOI":"10.1001\/jamahealthforum.2021.3626","article-title":"Trends in dialysis industry consolidation after medicare payment reform, 2006-2016","volume":"2","author":"Sloan","year":"2021","journal-title":"JAMA Health Forum."},{"issue":"11","key":"B32-20260821","doi-asserted-by":"crossref","first-page":"e213378","DOI":"10.1001\/jamahealthforum.2021.3378","article-title":"How did medicare payment reform affect highly concentrated dialysis markets?","volume":"2","author":"Parvathareddy","year":"2021","journal-title":"JAMA Health Forum."},{"issue":"3","key":"B33-20260821","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2215\/CJN.06340616","article-title":"Consolidation in the dialysis industry, patient choice, and local market competition","volume":"12","author":"Erickson","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"issue":"12","key":"B35-20260821","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2215\/CJN.0000000000000274","article-title":"Facility closures and distance traveled to receive dialysis care in the United States","volume":"18","author":"Niu","year":"2023","journal-title":"Clin J Am Soc Nephrol."},{"issue":"10","key":"B36-20260821","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1681\/ASN.2021020244","article-title":"Patient health outcomes following dialysis facility closures in the United States","volume":"32","author":"Niu","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"B40-20260821","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1377\/hlthaff.2022.01525","article-title":"Favorable selection in medicare advantage is linked to inflated benchmarks and billions in overpayments to plans","volume":"42","author":"Ryan","year":"2023","journal-title":"Health Aff (Millwood)."},{"issue":"24","key":"B41-20260821","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMhpr2302315","article-title":"The predominance of medicare advantage","volume":"389","author":"Jacobson","year":"2023","journal-title":"N Engl J Med."},{"issue":"5","key":"B42-20260821","first-page":"359","article-title":"Escalating growth of spending on medicare advantage plans: save medicare from insolvency and balance the budget","volume":"28","author":"Manchikanti","year":"2025","journal-title":"Pain Physician."},{"issue":"3","key":"B43-20260821","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/1468-0009.70042","article-title":"From disappointment to predominance: medicare advantage's ascendancy and transformation of medicare","volume":"103","author":"Mayes","year":"2025","journal-title":"Milbank Q."},{"issue":"8","key":"B45-20260821","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1377\/hlthaff.2024.01546","article-title":"Inside the meteoric rise of medicare advantage","volume":"44","author":"Lieberman","year":"2025","journal-title":"Health Aff (Millwood)."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:00:32Z","timestamp":1787302832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2215\/cjn.0000001161","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"2026-02-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}